Table 1.

Characteristics of cohort

	T2D (n = 18)	Controls (n = 27)	P value
Age (yr)	58 ± 6	57 ± 5	0.38
Race
Hispanic White	12	10
Caucasian	4	13
Hispanic Black	2	1
Asian	0	2
Native American	0	1
Duration postmenopausal (yr)	12 ± 9	8 ± 4	0.05
Number of fractures	5 (1 elbow, 1 ankle, 1 arm, 1 toe, 1 wrist)	5 (1 5th digit, 2 foot, 1 wrist, 1 toe)
Height (in.)	62 ± 2	63 ± 2	0.17
Weight (lb)	175 ± 42	158 ± 32	0.13
BMI (kg/m2)	32 ± 7	28 ± 6	0.06
Duration T2D (yr)	9 ± 6
Number of diabetes medications used
Metformin	15
Glipizide	5
Insulin	2
Glimepiride	1
Sitagliptin	1
Serum calcium (mg/dl)	9.4 ± 0.5	9.4 ± 0.3	0.75
Serum albumin (mg/dl)	4.3 ± 0.2	4.4 ± 0.2	0.65
Serum creatinine (mg/dl)	0.8 ± 0.2	0.8 ± 0.1	0.40
PTH (pg/ml)	46 ± 26	40.9 ± 20	0.46
Total alkaline phosphatase (U/liter)	97 ± 23	79 ± 29	0.03a
25(OH)D (ng/ml)	21 ± 11	29 ± 14	0.67
TSH (mIU/liter)	2.9 ± 4	2.6 ± 3	0.80
Glucose (mg/dl)	169 ± 94	107 ± 8	<0.001a
HbA1c (%)	8.4 ± 2b	5.8 ± 0.3	<0.001a
Lumbar spine
g/cm2	0.967 ± 0.16	0.920 ± 0.10	0.24
T score	−0.56 ± 1.5	−1.1 ± 1.0	0.28
Femoral neck
g/cm2	0.778 ± 0.15	0.708 ± 0.09	0.06
T score	−0.8 ± 1.2	−1.3 ± 0.7	0.08
Total hip
g/cm2	0.935 ± 0.18	0.835 ± 0.11	0.03a,c
T score	−0.2 ± 1.3	−0.9 ± 0.8	0.04a,c
1/3 distal radius
g/cm2	0.672 ± 0.07	0.654 ± 0.06	0.35
T score	−0.5 ± 1.2	−0.7 ± 1.0	0.61

To convert calcium to millimoles per liter, multiply by 0.25; albumin to grams per liter, multiply by 10; creatinine to micromoles per liter, multiply by 88.4; PTH to nanograms per liter, multiply by 1; 25(OH)D to nanomoles per liter, multiply by 2.496; glucose to millimoles per liter, multiply by 0.056.

^aP < 0.05.

^bSix T2D had HbA1c higher than 7.9%.

^cNo longer significant after adjusting for BMI.